loadpatents
name:-0.035435914993286
name:-0.023972034454346
name:-0.0003819465637207
Leblond; Bertrand Patent Filings

Leblond; Bertrand

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leblond; Bertrand.The latest application filed is for "substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (pde 10a)".

Company Profile
0.29.33
  • Leblond; Bertrand - Paris FR
  • Leblond; Bertrand - The Oxford Science Park GB
  • Leblond; Bertrand - Rouen FR
  • Leblond; Bertrand - Oxford GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
Grant 9,902,710 - Leblond , et al. February 27, 2
2018-02-27
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
Grant 9,828,349 - Leblond , et al. November 28, 2
2017-11-28
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
Grant 9,670,181 - Leblond , et al. June 6, 2
2017-06-06
DYRK1 inhibitors and uses thereof
Grant 9,446,044 - Leblond , et al. September 20, 2
2016-09-20
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a)
App 20160264549 - Leblond; Bertrand ;   et al.
2016-09-15
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
Grant 9,399,628 - Leblond , et al. July 26, 2
2016-07-26
1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20160083371 - Leblond; Bertrand ;   et al.
2016-03-24
Methods of using as analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
Grant 9,278,943 - Leblond , et al. March 8, 2
2016-03-08
Substituted 6, 7-dialkoxy-3-isoquinoline derivatives as inhibitors of phosphodiesterase 10 (PDE 10A)
Grant 9,200,016 - Leblond , et al. December 1, 2
2015-12-01
Substituted 6, 7-dialkoxy-3-isoquinoline Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a)
App 20150158895 - Leblond; Bertrand ;   et al.
2015-06-11
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-aminopropionic acid amides and related compounds having analgesic and/or immuno stimulant activity
Grant 8,927,589 - Leblond , et al. January 6, 2
2015-01-06
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde 10a)
App 20140309253 - Leblond; Bertrand ;   et al.
2014-10-16
Dyrk1 Inhibitors And Uses Thereof
App 20140275064 - Leblond; Bertrand ;   et al.
2014-09-18
Compounds having analgesic and/or immunostimulant activity
Grant 8,835,463 - Leblond , et al. September 16, 2
2014-09-16
Substituted 6,7-dialkoxy-3-isoquinolinol derivatives as inhibitors of phosphodiesterase 10 (PDE10A)
Grant 8,772,316 - Leblond , et al. July 8, 2
2014-07-08
1-aryl -1-hydroxy -2,3-diamino-propyl Amin Es, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20130310383 - Leblond; Bertrand ;   et al.
2013-11-21
1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds having analgesic and/or immuno stimulant activity
Grant 8,513,288 - Leblond , et al. August 20, 2
2013-08-20
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-aminopropionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20130202653 - Leblond; Bertrand ;   et al.
2013-08-08
Substituted Isoquinolines And Their Use As Tubulin Polymerization Inhibitors
App 20130131018 - Leblond; Bertrand ;   et al.
2013-05-23
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
Grant 8,431,599 - Leblond , et al. April 30, 2
2013-04-30
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20130005717 - Leblond; Bertrand ;   et al.
2013-01-03
3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
Grant 8,288,556 - Leblond , et al. October 16, 2
2012-10-16
Methods Of Using As Analgesics 1-benzyl-1-hydroxy-2, 3-diamino-propyl Amines, 3-benzyl-3-hyrdroxy-2-amino-propionic Acid Amides And Related Compounds
App 20120225881 - Leblond; Bertrand ;   et al.
2012-09-06
Methods For Treating Diseases Of The Retina
App 20120214842 - Donello; John E. ;   et al.
2012-08-23
Substituted 6,7-dialkoxy-3-isoquinolinol Derivatives As Inhibitors Of Phosphodiesterase 10 (pde10a)
App 20120214837 - Leblond; Bertrand ;   et al.
2012-08-23
Compounds Having Analgesic And/or Immunostimulant Activity
App 20120157497 - Leblond; Bertrand ;   et al.
2012-06-21
3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic activity
Grant 8,168,631 - Leblond , et al. May 1, 2
2012-05-01
Compounds having analgesic and/or immunostimulant activity
Grant 8,153,666 - Leblond , et al. April 10, 2
2012-04-10
1-aryl-1-hydroxy-2,3-diamino-propyl Amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl Amines And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20110288094 - Leblond; Bertrand ;   et al.
2011-11-24
Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
Grant 8,030,296 - Potter , et al. October 4, 2
2011-10-04
3-heteroaryl-3-hydroxy-2-amino-propyl amines and related compounds having analgesic and/or immuno stimlant activity
Grant 8,013,000 - Leblond , et al. September 6, 2
2011-09-06
Tricyclic hydroxamate and benzamide derivatives, compositions and methods
Grant 7,923,579 - Leblond , et al. April 12, 2
2011-04-12
Compounds And Methods For Modulating Rho Gtpases
App 20100120810 - Leblond; Bertrand ;   et al.
2010-05-13
Compounds Having Analgesic And/or Immunostimulant Activity
App 20090318499 - Leblond; Bertrand ;   et al.
2009-12-24
3-(4-fluorophenyl)-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic Activity
App 20090281085 - Leblond; Bertrand ;   et al.
2009-11-12
Novel Compounds And Methods Of Treating Cell Proliferative Diseases, Retinopathies And Arthritis
App 20090216014 - LEBLOND; Bertrand ;   et al.
2009-08-27
Compounds and methods for treatment of amyloid-beta-peptide related disorders
App 20090118282 - Leblond; Bertrand ;   et al.
2009-05-07
Methods of Treating Nervous Disorders
App 20090093471 - Desire; Laurent ;   et al.
2009-04-09
Compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
Grant 7,514,432 - Leblond , et al. April 7, 2
2009-04-07
Methods Of Using As Analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl Amines, 3-benzyl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds
App 20090088433 - Leblond; Bertrand ;   et al.
2009-04-02
3-aryl-3-hydroxy-2-amino-propionic Acid Amides, 3-heteroaryl-3-hydroxy-2-amino-propionic Acid Amides And Related Compounds Having Analgesic And/or Immuno Stimulant Activity
App 20090036436 - Leblond; Bertrand ;   et al.
2009-02-05
3-Heteroaryl-3-Hydroxy-2-Amino-Propyl Amines And Related Compounds Having Analgesic And/Or Immuno Stimlant Activity
App 20080312236 - Leblond; Bertrand ;   et al.
2008-12-18
Tricyclic hydroxamate and benzamide derivatives, compositions and methods
App 20070129368 - Leblond; Bertrand ;   et al.
2007-06-07
Methods of treating nervous disorders
App 20070027146 - Desire; Laurent ;   et al.
2007-02-01
Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
App 20060281719 - Lloyd Potter; Barry Victor ;   et al.
2006-12-14
Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
Grant 7,119,081 - Potter , et al. October 10, 2
2006-10-10
Novel compounds and methods of treating cell proliferative diseases, retinopathies and arthritis
App 20060183749 - Leblond; Bertrand ;   et al.
2006-08-17
17-aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
Grant 7,067,503 - Potter , et al. June 27, 2
2006-06-27
Compounds and methods of treating cell proliferative diseases
App 20050054629 - Leblanc, Veronique ;   et al.
2005-03-10
Oestrogen-17-sulphamates as inhibitors of steroid sulphatase
App 20030225051 - Potter, Barry Victor Lloyd ;   et al.
2003-12-04
17-Aryl linker derivatised estrogen 3-sulphamates as inhibitors of steroid sulphatase
App 20030203855 - Potter, Barry Victor Lloyd ;   et al.
2003-10-30
Tripeptidylpeptidase inhibitors
App 20030027743 - Rose, Christiane ;   et al.
2003-02-06
Process for preparation of halogenated or pseudohalogenated cyclic organic compounds
Grant 5,817,890 - Duhamel , et al. October 6, 1
1998-10-06
Synthesis intermediates containing a hexane ring and processes for their preparation
Grant 5,424,460 - Duhamel , et al. June 13, 1
1995-06-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed